Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?

BACKGROUND: Despite evidence that shows no survival advantage, many older patients receive primary androgen-deprivation therapy (PADT) shortly after the diagnosis of localized prostate cancer (PCa). OBJECTIVE: This study evaluates whether the early use of PADT affects the subsequent receipt of addit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lu-Yao, Grace L., Albertsen, Peter C., Li, Hui, Moore, Dirk F., Shih, Weichung, Lin, Yong, DiPaola, Robert S., Yao, Siu-Long
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472155/
https://ncbi.nlm.nih.gov/pubmed/22608160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars